Department of Dermatology - Open Access Policy Deposits
Parent: School of Medicine
eScholarship stats: Breakdown by Item for July through October, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 44q8g6b8 | Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). | 577 | 448 | 129 | 77.6% |
| 3455571b | Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation | 572 | 137 | 435 | 24.0% |
| 0zf2s1cf | Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia | 490 | 214 | 276 | 43.7% |
| 6hz8s1mh | Eccrine chromhidrosis secondary to hyperbilirubinemia | 489 | 140 | 349 | 28.6% |
| 02k9z6qd | Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations | 472 | 156 | 316 | 33.1% |
| 5c88q182 | Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition | 413 | 150 | 263 | 36.3% |
| 1rd5q5tz | Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis | 339 | 159 | 180 | 46.9% |
| 5fs883zh | Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies | 330 | 64 | 266 | 19.4% |
| 1h87c6v1 | S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis | 317 | 220 | 97 | 69.4% |
| 69s5d7c2 | Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes | 309 | 89 | 220 | 28.8% |
| 8z66m3xd | Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial | 302 | 104 | 198 | 34.4% |
| 2dn263n7 | Skin neurogenic inflammation | 281 | 103 | 178 | 36.7% |
| 08j6337f | Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris | 278 | 97 | 181 | 34.9% |
| 5sp112v7 | Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus | 272 | 197 | 75 | 72.4% |
| 62d7n4g9 | Designing a broad-spectrum integrative approach for cancer prevention and treatment | 270 | 104 | 166 | 38.5% |
| 1rw3692c | Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis | 269 | 56 | 213 | 20.8% |
| 25j8m068 | Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne | 261 | 197 | 64 | 75.5% |
| 4mj865qb | Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel | 249 | 159 | 90 | 63.9% |
| 2800q59v | TREM2 macrophages induced by human lipids drive inflammation in acne lesions | 245 | 133 | 112 | 54.3% |
| 76r5t591 | Guidelines of care for the management of atopic dermatitis Section 3. Management and treatment with phototherapy and systemic agents | 243 | 52 | 191 | 21.4% |
| 4pn6h3g6 | The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis | 240 | 43 | 197 | 17.9% |
| 55q795hc | Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis | 240 | 112 | 128 | 46.7% |
| 38g465s4 | Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis | 234 | 82 | 152 | 35.0% |
| 9vr045f7 | Guidelines of care for the management of atopic dermatitis Section 4. Prevention of disease flares and use of adjunctive therapies and approaches | 231 | 149 | 82 | 64.5% |
| 0k43s8nm | Differential Diagnosis of Chronic Spontaneous Urticaria | 227 | 83 | 144 | 36.6% |
| 8p66q9fv | Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum | 224 | 54 | 170 | 24.1% |
| 0vp716bx | Pediatric chronic hand eczema: Epidemiology, clinical presentation, and management | 222 | 99 | 123 | 44.6% |
| 5r79d67k | Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature | 222 | 63 | 159 | 28.4% |
| 67t6b870 | Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel | 219 | 46 | 173 | 21.0% |
| 2qr3w771 | Urgent safety considerations for dermatologic surgeons in the COVID-19 pandemic | 212 | 62 | 150 | 29.2% |
| 68c7v95d | Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome | 210 | 69 | 141 | 32.9% |
| 3m85j4j2 | DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth | 209 | 142 | 67 | 67.9% |
| 7gn5j3gp | Incomplete human reference genomes can drive false sex biases and expose patient-identifying information in metagenomic data | 209 | 57 | 152 | 27.3% |
| 0g0537ph | Beneficial Effects of Early Pulsed Dye Laser Therapy in Individuals with Infantile Hemangiomas | 205 | 27 | 178 | 13.2% |
| 5kk7h8hg | Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study | 204 | 45 | 159 | 22.1% |
| 49f6450d | Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris | 203 | 96 | 107 | 47.3% |
| 2z6036qj | Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis | 199 | 134 | 65 | 67.3% |
| 2bv4q0k3 | Obesity alters pathology and treatment response in inflammatory disease | 195 | 100 | 95 | 51.3% |
| 8sq2t665 | Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). | 194 | 165 | 29 | 85.1% |
| 9dv5d6nh | Novel tretinoin 0.05% lotion for the once‐daily treatment of moderate‐to‐severe acne vulgaris in a preadolescent population | 192 | 134 | 58 | 69.8% |
| 2qq240fn | Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface | 190 | 30 | 160 | 15.8% |
| 2vz565gs | Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus | 189 | 105 | 84 | 55.6% |
| 216788xg | Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study | 188 | 91 | 97 | 48.4% |
| 05j80943 | Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies | 183 | 76 | 107 | 41.5% |
| 47q8p2w7 | Nevoid melanoma and eruptive nevi from erlotinib | 181 | 50 | 131 | 27.6% |
| 27v10695 | Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes | 178 | 108 | 70 | 60.7% |
| 2xn7z5c4 | Botulinum toxin blocks mast cells and prevents rosacea like inflammation | 177 | 90 | 87 | 50.8% |
| 5xs3g48j | Acne and Rosacea | 174 | 76 | 98 | 43.7% |
| 0sg0z14s | Genitogluteal porokeratosis in an HIV-positive man: a case report and review of the literature on genital porokeratosis | 171 | 63 | 108 | 36.8% |
| 3pb085n6 | Association of Psychiatric Comorbidities With Chronic Urticaria: A Nested Case‐Control Study in the All of Us Research Program | 167 | 23 | 144 | 13.8% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.